Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXN PR versus OxyPR crossover study on intestinal microbiota and gastrointestinal effects in adults with non-malignant pain
2012-001772-11Phase 2Completed
- Sponsor
- Mundipharma Research
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxycodone + naloxone and oxycodone in pain (2 arms), sponsored by Mundipharma Research. Primary endpoint: Quantitative analysis of intestinal microbiota. Started Oct 2013; status: completed.
02
Drugs
oxycodone + naloxoneoxycodone
03
Conditions
pain
Beyond the preview
Go deeper on 2012-001772-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001772-11.